Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Objective</h3><p>Mutations of the cyclin‐dependent kinase‐like 5 (<i>CDKL5</i>) gene cause severe neurodevelopmental disorders characterized by intractable epilepsy, intellectual disability, and autism. Multiple mouse models generated for mechanistic studies have exhibited phenotypes similar to some human pathological features, but none of the models has developed one of the major symptoms affecting CDKL5 deficiency disorder (CDD) patients: intractable recurrent seizures. As disrupted neuronal excitation/inhibition balance is closely associated with the activity of glutamatergic and γ‐aminobutyric acidergic (GABAergic) neurons, our aim was to study the effect of the loss of CDKL5 in different types of neurons on epilepsy. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>Using the Cre‐LoxP system, we generated conditional knockout (cKO) mouse lines allowing CDKL5 deficiency in glutamatergic or GABAergic neurons. We employed noninvasive video recording and in vivo electrophysiological approaches to study seizure activity in these <i>Cdkl5</i> cKO mice. Furthermore, we conducted Timm staining to confirm a morphological alteration, mossy fiber sprouting, which occurs with limbic epilepsy in both human and mouse brains. Finally, we performed whole‐cell patch clamp in dentate granule cells to investigate cell‐intrinsic properties and synaptic excitatory activity. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>We demonstrate that Emx1‐ or CamK2α‐derived <i>Cdkl5</i> cKO mice manifest high‐frequency spontaneous seizure activities recapitulating the epilepsy of CDD patients, which ultimately led to sudden death in mice. However, <i>Cdkl5</i> deficiency in GABAergic neurons does not generate such seizures. The seizures were accompanied by typical epileptic features including higher amplitude spikes for epileptiform discharges and abnormal hippocampal mossy fiber sprouting. We also found an increase in spontaneous and miniature excitatory postsynaptic current frequencies but no change in amplitudes in the dentate granule cells of Emx1‐cKO mice, indicating enhanced excitatory synaptic activity. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Significance</h3><p>Our study demonstrates that <i>Cdkl5</i> cKO mice, serving as an animal model to study recurrent spontaneous seizures, have potential value for the pathological study of CDD‐related seizures and for therapeutic innovation. </p></section>

Research progress on the pathogenesis of CDKL5 pathogenic variants and related encephalopathy

Novel CDKL5 Mutations Were Found in Patients in China: Retrospective Investigation in Cases of CDKL5-related Disorders

Novel CDKL5 targets identified in human iPSC-derived neurons

Report of 7 CDKL5 disorder cases

CDKL5 Deficiency Disorder: Some Lessons Learned 20 Years After the First Description

Deletions in the CDKL5 5′ untranslated region lead to CDKL5 deficiency disorder

Clinical features and gene mutational spectrum of CDKL5 -related diseases in a cohort of Chinese patients

The CDKL5 kinase undergoes liquid-liquid phase separation driven by a serine-rich C-terminal region and impaired by neurodevelopmental disease-related truncations

Discovery and characterization of a specific inhibitor of serine-threonine kinase cyclin-dependent kinase-like 5 (CDKL5) demonstrates role in hippocampal CA1 physiology

CDKL5 deficiency in forebrain glutamatergic neurons results in recurrent spontaneous seizures

Preclinical studies of gene replacement therapy for CDKL5 deficiency disorder

Neuronal hyperexcitability and ion channel dysfunction in CDKL5-deficiency patient iPSC-derived cortical organoids

CDKL5 Deficiency Disorder-Related Epilepsy: A Review of Current and Emerging Treatment

Temporal manipulation of Cdkl5 reveals essential postdevelopmental functions and reversible CDKL5 deficiency disorder–related deficits

The Role of Cdk5 in Neurological Disorders

Encephalopathies with KCNC1 variants: genotype-phenotype-functional correlations

Cyclin-Dependent Kinase-Like 5 Deficiency Disorder: A Calcium Channelopathy?

CCDC22 variants caused X-linked focal epilepsy and focal cortical dysplasia

Epilepsy-linked kinase CDKL5 phosphorylates voltage-gated calcium channel Cav2.3, altering inactivation kinetics and neuronal excitability

Longitudinal, multidimensional, observational study of 15 patients with CDKL5 Deficiency Disorder

Cyclin-dependent Kinase 5 and Neurodegenerative Diseases